Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Tables)

3 Months Ended

Oct. 31, 2021

Three months ended October 31, 2021	Clinical Services			Products			Therapeutics			Other			Consolidated
Revenues	$	19,741		$	6,778			—			—		$	26,519

Operating costs and expenses:
Cost of revenues		11,203			4,070			—			—			15,273
Research and development		7			732			5			—			744
Selling, general and administrative		6,001			3,095			—			1,956			11,052
Legal fee expense		57			13			—			1,212			1,282
Total operating costs and expenses		17,268			7,910			5			3,168			28,351

Operating income (loss)		2,473			(1,132	)		(5	)		(3,168	)		(1,832	)

Other income (expense):
Interest, net		(2	)		9			—			32			39
Other		49			2			—			(196	)		(145	)
Foreign exchange loss		—			(381	)		—			—			(381	)
Net income (loss)	$	2,520		$	(1,502	)	$	(5	)	$	(3,332	)	$	(2,319	)

Depreciation and amortization included above	$	418			212			—			71			701

Share-based compensation included in above:
Selling, general and administrative		20			19			—			173			212
Cost of revenues		4			—			—			—			4
Total	$	24			19			—			173			216

Capital expenditures	$	310			486			—			237			1,033

Three months ended October 31, 2020	Clinical Services			Products			Therapeutics			Other			Consolidated
Revenues – Services and Products	$	21,223		$	7,432			—			—		$	28,655

Operating costs and expenses:
Cost of revenues		12,995			3,763			—			—			16,758
Research and development		121			592		$	33			—			746
Selling, general and administrative		6,098			2,445			17		$	1,454			10,014
Legal and related expenses		25			5			—			610			640
Total operating costs and expenses		19,239			6,805			50			2,064			28,158

Operating income (loss)		1,984			627			(50	)		(2,064	)		497

Other income (expense):
Interest, net		(6	)		10			—			(55	)		(51	)
Other		15			2			—			—			17
Foreign exchange loss		—			(164	)		—			—			(164	)
Net income (loss)	$	1,993		$	475		$	(50	)	$	(2,119	)	$	299

Depreciation and amortization included above	$	409		$	185		$	—		$	66		$	660

Share-based compensation included in above:
Selling, general and administrative		9			16			—			129			154
Cost of revenues		13			—			—			—			13
Total	$	22		$	16		$	—		$	129		$	167

Capital expenditures	$	540		$	44		$	—		$	33		$	617